Generic Name：

Fluticasone Propionate Nebuliser Suspension

Indications：

Treatment of mild to moderate acute asthma exacerbations in children and adolescents aged 4 to 16 years.

Fluticasone propionate has significant anti-inflammatory effects in the lungs.

In patients with asthma who previously only received bronchodilator therapy or other prophylactic treatments, fluticasone propionate can reduce asthma symptoms and acute exacerbations.

While quick-relief bronchodilators can generally alleviate relatively short-lived acute exacerbation symptoms, longer-lasting acute exacerbations require prompt treatment with corticosteroids to control inflammation.

Dosage forms and strengths: Inhalation suspension: 0.5 mg/2 mL